Clinical Study
Intravenous Methadone for Severe Cancer Pain: A Presentation of 10 Cases
Table 1
Patient’s characteristics.
| Patients | Sex | Age | Type of cancer | Pain treatment (mg/day) |
| 1 | F | 32 | Vulvar sarcoma | Hydromorphone 300/ketamine 150 (i.v.) | 2 | F | 48 | Lung (SCLC) | Oral methadone 210 | 3 | M | 49 | Rectum | Oral methadone 180 | 4 | F | 20 | Ewing sarcoma | Oral methadone 240 | 5 | M | 49 | Colon | Morphine 900 (i.v.) | 6 | F | 60 | Vulvar carcinoma | Oral methadone 240 | 7 | F | 64 | Vulvar carcinoma | Hydromorphone 50 (i.v.) | 8 | F | 37 | Vaginal carcinoma | Oral methadone 45 | 9 | F | 55 | Uterine carcinoma | Fentanyl 300 (g/H) | 10 | M | 41 | Pelvic angiosarcoma | Hydromorphone 130/ketamine 100 |
|
|